Código QR (código de barras bidimensional)

Efficacy and safety of transarterial chemoembolization plus donafenib with or without camrelizumab for unresectable hepatocellular carcinoma: a propensity score matching analysis

PurposeTo compare the efficacy and safety of transarterial chemoembolization plus donafenib (TACE+D) and TACE plus donafenib combined with camrelizumab (TACE+D+C) in unresectable hepatocellular carcinoma (uHCC), using propensity score matching (PSM) to minimize selection bias.MethodsA single-center...

ver descrição completa

Na minha lista:
Principais autores: Qi Zhang, Zhenwu Lei, Hezi Qing, Xingwu Xie
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2026-04-01
coleção:Frontiers in Immunology
Assuntos:
Camrelizumab
donafenib
interventional treatment
transarterial chemoembolization
unresectable hepatocellular carcinoma
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fimmu.2026.1694973/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados